369 related articles for article (PubMed ID: 26432044)
1. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
2. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
[TBL] [Abstract][Full Text] [Related]
3. Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas.
Liu LH; Li H; Cheng XX; Kong QY; Chen XY; Wu ML; Li Y; Liu J; Li C
Mol Med Rep; 2017 Feb; 15(2):847-852. PubMed ID: 28035384
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
5. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
[TBL] [Abstract][Full Text] [Related]
7. Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.
Shu XH; Li H; Sun XX; Wang Q; Sun Z; Wu ML; Chen XY; Li C; Kong QY; Liu J
PLoS One; 2011; 6(11):e27484. PubMed ID: 22096581
[TBL] [Abstract][Full Text] [Related]
8. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101
[TBL] [Abstract][Full Text] [Related]
9. Nucleocytoplasmic shuttling of persistently activated STAT3.
Herrmann A; Vogt M; Mönnigmann M; Clahsen T; Sommer U; Haan S; Poli V; Heinrich PC; Müller-Newen G
J Cell Sci; 2007 Sep; 120(Pt 18):3249-61. PubMed ID: 17726064
[TBL] [Abstract][Full Text] [Related]
10. Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells.
Zhang P; Li H; Yang B; Yang F; Zhang LL; Kong QY; Chen XY; Wu ML; Liu J
Genes Cancer; 2014 May; 5(5-6):154-64. PubMed ID: 25061499
[TBL] [Abstract][Full Text] [Related]
11. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation.
Wu M; Song D; Li H; Ahmad N; Xu H; Yang X; Wang Q; Cheng X; Deng S; Shu X
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298405
[TBL] [Abstract][Full Text] [Related]
13. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells.
Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS
Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease.
Gu Q; Kong Y; Yu ZB; Bai L; Xiao YB
Biochimie; 2011 May; 93(5):909-20. PubMed ID: 21354254
[TBL] [Abstract][Full Text] [Related]
16. GRIM‑19‑mediated Stat3 activation is a determinant for resveratrol‑induced proliferation and cytotoxicity in cervical tumor‑derived cell lines.
Li YG; Xia HJ; Tao JP; Xin P; Liu MY; Li JB; Zhu W; Wei M
Mol Med Rep; 2015 Feb; 11(2):1272-7. PubMed ID: 25351437
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation.
Ogata Y; Osaki T; Naka T; Iwahori K; Furukawa M; Nagatomo I; Kijima T; Kumagai T; Yoshida M; Tachibana I; Kawase I
Neoplasia; 2006 Oct; 8(10):817-25. PubMed ID: 17032498
[TBL] [Abstract][Full Text] [Related]
18. Suppressed Th17 levels correlate with elevated PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute simian immunodeficiency virus infection.
Bixler SL; Sandler NG; Douek DC; Mattapallil JJ
J Virol; 2013 Jun; 87(12):7093-101. PubMed ID: 23596301
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.
Kim C; Baek SH; Um JY; Shim BS; Ahn KS
BMC Nephrol; 2016 Feb; 17():19. PubMed ID: 26911335
[TBL] [Abstract][Full Text] [Related]
20. Expression of STATs and their inhibitors SOCS and PIAS in brain tumors. In vitro and in vivo study.
Ehrmann J; Strakova N; Vrzalikova K; Hezova R; Kolar Z
Neoplasma; 2008; 55(6):482-7. PubMed ID: 18999875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]